Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (22 ops.)
Latest filing published 19 Mar 2026 for Medpace Holdings, Inc., €12.6M.
Filing timeline
BuySaleJesse J. Geiger
Insider track record
Disclosed buys
0
Disclosed sells
22
Signal history
Jesse J. Geiger: trading record in brief
Jesse J. Geiger, CFO & COO, Lab Operations at Medpace Holdings, Inc., has 41 filings published from March 2, 2018 to March 19, 2026. Sales are the core of the market activity: 22, worth EUR 72,822,473 in total, with a median of EUR 995,473. The three largest are dated July 24, 2025 (EUR 16,111,125), March 17, 2026 (EUR 12,553,717) and November 5, 2025 (EUR 11,151,829). No purchase is recorded. The record also counts 16 option exercises, 2 grants and one filing of another kind.
The calendar has a break: 3 filings in 2018, 7 in 2019, 9 in 2020, 6 in 2021, 2 in 2022, nothing between 2022 and 2024, then 5 in 2024, 7 in 2025 and 2 in 2026. Seven filings fall in the last twelve months, 4 of them sales. They come out a median of 2 days after the trade.
At Medpace Holdings, Inc., 18 of Geiger's trades fall within 30 days of a trade by Stephen P. Ewald, 13 of one by August J. Troendle, 10 of one by Susan E. Burwig and 8 of one by Medpace Investors, LLC, always in the same direction.
Companies and markets linked to Jesse J. Geiger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations41 total
31,707 shares@ US$455.3012.7% of flowCommon StockSEC:0001677399-26-000002:1
31,707 shares@ US$138.8711.4% of flowCommon StockSEC:0001677399-26-000002:0
21,503 shares@ US$595.6633.3% of flowCommon StockSEC:0001677399-25-000006:0
19,460 shares@ US$605.1210.2% of flowCommon StockSEC:0001677399-25-000004:1
3,568 shares@ US$166.730.5% of flowCommon StockSEC:0001677399-25-000004:2
3,568 shares@ US$585.001.8% of flowCommon StockSEC:0001677399-25-000004:3
19,460 shares@ US$166.730.018% mcap8.3% of flowCommon StockSEC:0001677399-25-000004:0
41,801 shares@ US$453.1116.2% of flowCommon StockSEC:0001668397-25-000095:1
41,801 shares@ US$107.9311.5% of flowCommon StockSEC:0001668397-25-000095:0
15,000 shares@ US$32.051.4% of flowCommon StockSEC:0001668397-24-000178:0
22,321 shares@ US$403.038.4% of flowCommon StockSEC:0001668397-24-000051:1
17,679 shares@ US$90.651.5% of flowCommon StockSEC:0001668397-24-000051:2
22,321 shares@ US$90.655.6% of flowCommon StockSEC:0001668397-24-000051:0
2,558 shares@ US$393.5052.8% of flowCommon StockSEC:0001668397-24-000039:0
7,000 shares@ US$230.001.6% of flowCommon StockSEC:0001567619-22-020558:1
7,000 shares@ US$28.320.6% of flowCommon StockSEC:0001567619-22-020558:0
10,000 shares@ US$211.363.9% of flowCommon StockSEC:0001567619-21-018874:1
10,000 shares@ US$28.320.7% of flowCommon StockSEC:0001567619-21-018874:0
3,000 shares@ US$28.320.2% of flowCommon StockSEC:0000899243-21-016132:0
3,000 shares@ US$180.001.0% of flowCommon StockSEC:0000899243-21-016132:1
4,000 shares@ US$23.000.2% of flowCommon StockSEC:0001567619-21-003082:0
4,000 shares@ US$160.001.1% of flowCommon StockSEC:0001567619-21-003082:1
4,200 shares@ US$23.000.2% of flowCommon StockSEC:0001567619-20-021199:0
4,200 shares@ US$142.001.4% of flowCommon StockSEC:0001567619-20-021199:1
3,700 shares@ US$23.000.2% of flowCommon StockSEC:0001567619-20-016319:0
25 of 41 declarations
